Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Accumulated Expenses (2022 - 2025)

Envoy Medical's Accumulated Expenses history spans 4 years, with the latest figure at $7.6 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $7.6 million for Q4 2025, up 1349.53% from a year ago — trailing twelve months through Dec 2025 was $7.6 million (up 1349.53% YoY), and the annual figure for FY2025 was $7.6 million, up 1349.53%.
  • Accumulated Expenses for Q4 2025 was $7.6 million at Envoy Medical, up from $250000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $7.6 million in Q4 2025 to a low of $250000.0 in Q3 2025.
  • The 4-year median for Accumulated Expenses is $4.4 million (2023), against an average of $3.8 million.
  • Peak annual rise in Accumulated Expenses hit 1349.53% in 2025, while the deepest fall reached 96.35% in 2025.
  • Year by year, Accumulated Expenses stood at $608000.0 in 2022, then plummeted by 48.85% to $311000.0 in 2023, then skyrocketed by 69.45% to $527000.0 in 2024, then skyrocketed by 1349.53% to $7.6 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $7.6 million, $250000.0, and $4.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.